Home UVA Health researchers discover indication for patients who recover well from severe COVID-19
Virginia

UVA Health researchers discover indication for patients who recover well from severe COVID-19

Rebecca Barnabi
(© peterschreiber.media – stock.adobe.com)

UVA Health researchers have discovered a potential way to predict which patients with severe COVID-19 are likely to recover well and which are likely to suffer “long-haul” lung problems.

The finding could help doctors better personalize treatments for individual patients.

UVA’s new research also alleviates concerns that severe COVID-19 could trigger relentless, ongoing lung scarring akin to the chronic lung disease known as idiopathic pulmonary fibrosis, the researchers report. Such continuing lung damage would mean that patients’ ability to breathe would continue to worsen over time.

“We are excited to find that people with long-haul COVID have an immune system that is totally different from people who have lung scarring that doesn’t stop,” researcher Dr. Catherine A. Bonham, a pulmonary and critical care expert who serves as scientific director of UVA Health’s Interstitial Lung Disease Program, said. “This offers hope that even patients with the worst COVID do not have progressive scarring of the lung that leads to death.”

Up to 30 percent of patients hospitalized with severe COVID-19 continue to suffer persistent symptoms months after recovering from the virus. Many of these patients develop lung scarring – some early on in their hospitalization, and others within six months of their initial illness, prior research has found. Bonham and her collaborators wanted to better understand why this scarring occurs, to determine if it is similar to progressive pulmonary fibrosis and to see if there is a way to identify patients at risk.

The researchers followed 16 UVA Health patients who survived severe COVID-19. Fourteen had been hospitalized and placed on a ventilator. All continued to have trouble breathing and suffered fatigue and abnormal lung function at their first outpatient checkup.

After six months, the researchers found that the patients could be divided into two groups: One group’s lung health improved, prompting the researchers to label them “early resolvers,” while the other group, dubbed “late resolvers,” continued to suffer lung problems and pulmonary fibrosis.

Looking at blood samples taken before the patients’ recovery began to diverge, the UVA team found that the late resolvers had significantly fewer immune cells known as monocytes circulating in their blood. White blood cells play a critical role in our ability to fend off disease, and the cells were abnormally depleted in patients who continued to suffer lung problems compared both to those who recovered and healthy control subjects.

The decrease in monocytes correlated with the severity of the patients’ ongoing symptoms, which suggests that doctors may be able to use a simple blood test to identify patients likely to become long-haulers and to improve their care.

“About half of the patients we examined still had lingering, bothersome symptoms and abnormal tests after six months,” Bonham said. “We were able to detect differences in their blood from the first visit, with fewer blood monocytes mapping to lower lung function.”

The researchers also wanted to determine if severe COVID-19 could cause progressive lung scarring as in idiopathic pulmonary fibrosis. They found that the two conditions had very different effects on immune cells, suggesting that even when the symptoms were similar, the underlying causes were very different. This held true even in patients with the most persistent long-haul COVID-19 symptoms.

“Idiopathic pulmonary fibrosis is progressive and kills patients within three to five years,” Bonham said. “It was a relief to see that all our COVID patients, even those with long-haul symptoms, were not similar.”

Because of the small numbers of participants in UVA’s study, and because they were mostly male (for easier comparison with IPF, a disease that strikes mostly men), the researchers say larger, multi-center studies are needed to bear out the findings. But they are hopeful that their new discovery will provide doctors a useful tool to identify COVID-19 patients at risk for long-haul lung problems and help guide them to recovery.

“We are only beginning to understand the biology of how the immune system impacts pulmonary fibrosis,” Bonham said. “My team and I were humbled and grateful to work with the outstanding patients who made this study possible.”

The researchers have published their findings in the scientific journal Frontiers in Immunology. The research was supported by the National Institutes of Health, NIH’s National Heart, Lung and Blood Institute, UVA’s Engineering in Medicine Seed Fund, the UVA Global Infectious Diseases Institute’s COVID-19 Rapid Response, a UVA Robert R. Wagner Fellowship and a Sture G. Olsson Fellowship in Engineering.

 

Support AFP

Newsletter

Featured Video

 

 




Latest News

ben cline
Politics, Virginia

Update: Ben Cline announces more town halls, with more waitlists

National Christmas Tree
Local

Highland County red spruce selected to serve as National Christmas Tree

A tree from the mountains of Highland County has been selected to serve as the National Christmas Tree, for display on the mess that serves as the White House grounds, with construction going on everywhere because our president wants to build monuments to himself.

school bus arm
Local

Albemarle County schools closed because of another major administrative screwup

More than 500 people hired in the past three years to work for Albemarle County Public Schools were not checked against the Child Protective Services Central Registry.

newspaper online news AFP mobile phone newsfeed
Local

AFP needs to do more: Just warning you, we’re going to ask for your help to get there

uva central grounds
Football, Go 'Hoos

Conservative alums lead the fight to hold UVA accountable for the failures of Nov. 13

mobile games casino phone computer
Politics, Virginia

State AGs pushing Trump FCC to take real steps to get rid of annoying robocalls

uva basketball thijs de ridder
Basketball, Go 'Hoos

UVA Basketball: NBA-like early schedule, tempo, defense, Gertrude/de Ridder